Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP2789553B2 - Method for producing enzyme-treated yogurt powder having immunological activity - Google Patents
[go: Go Back, main page]

JP2789553B2 - Method for producing enzyme-treated yogurt powder having immunological activity - Google Patents

Method for producing enzyme-treated yogurt powder having immunological activity

Info

Publication number
JP2789553B2
JP2789553B2 JP6256250A JP25625094A JP2789553B2 JP 2789553 B2 JP2789553 B2 JP 2789553B2 JP 6256250 A JP6256250 A JP 6256250A JP 25625094 A JP25625094 A JP 25625094A JP 2789553 B2 JP2789553 B2 JP 2789553B2
Authority
JP
Japan
Prior art keywords
yogurt
powder
enzyme
immunological activity
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP6256250A
Other languages
Japanese (ja)
Other versions
JPH0889166A (en
Inventor
野 厚 浜
政 秀 谷
々 木 隆 志 佐
川 智 裕 黒
辺 博 田
山 真 由 美 牧
崎 勝 也 石
井 弘 幸 金
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ENU SHII EFU KK
KAGAKU SHIRYO KENKYUSHO KK
ZENKOKU NOGYO KYODOKUMIAI RENGOKAI
Original Assignee
ENU SHII EFU KK
KAGAKU SHIRYO KENKYUSHO KK
ZENKOKU NOGYO KYODOKUMIAI RENGOKAI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ENU SHII EFU KK, KAGAKU SHIRYO KENKYUSHO KK, ZENKOKU NOGYO KYODOKUMIAI RENGOKAI filed Critical ENU SHII EFU KK
Priority to JP6256250A priority Critical patent/JP2789553B2/en
Publication of JPH0889166A publication Critical patent/JPH0889166A/en
Application granted granted Critical
Publication of JP2789553B2 publication Critical patent/JP2789553B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Fodder In General (AREA)
  • Dairy Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は免疫賦活作用を有するヨ
ーグルト粉末の製造に関する。さらに詳しくは、酵素に
よりヨーグルト中の蛋白質のカゼイン部分を水に可溶化
し免疫賦活物質を失活させることなくヨーグルト粉末を
製造する方法に関する。かくして得られるヨーグルト粉
末は食品、飼料として利用される。
The present invention relates to the production of yogurt powder having an immunostimulating effect. More specifically, the present invention relates to a method for solubilizing a casein portion of a protein in yogurt in water with an enzyme to produce yogurt powder without deactivating immunostimulating substances. The yogurt powder thus obtained is used as food and feed.

【0002】[0002]

【従来の技術】従来、ヨーグルトまたはヨーグルト残滓
を飼料として使用する場合、直接代用乳等に混合し与え
るか、またはふすま等と混合して乾燥後使用していた。
しかしヨーグルトを生で与える場合、形態が液状のため
代用乳等に混合し給与する場合には可能であるが、粉状
飼料に混入する場合は、給餌器を濡らしかつ飼料の腐敗
の原因となるため、適当な給与方法ではなかった。ま
た、ふすま等と混合して乾燥する場合は、製品の均一性
が失われ飼料としての価値は低かった。さらに直接乾燥
しても、得られる製品が塊状でその上吸湿性が高いこと
等から、粉砕が難しく一般飼料としての流通ができなか
った。さらにヨーグルトを直接給与する場合や、ふすま
等と混合して乾燥物として給与する場合、元来ヨーグル
トに含まれている乳酸菌類の免疫賦活物質の適切な活用
・投与が行えず、十分にその効果を引き出すまでには至
らなかった。
2. Description of the Related Art Conventionally, when yogurt or yogurt residue is used as feed, it has been used either by directly mixing it with milk substitute or the like, or by mixing it with bran and the like and then drying it.
However, when yogurt is given raw, it is possible to mix and feed it into milk substitutes because it is in a liquid form, but when mixed into powdered feed, it can wet the feeder and cause spoilage of the feed Therefore, it was not an appropriate salary method. In addition, when mixed with bran or the like and dried, the uniformity of the product was lost and the value as feed was low. Furthermore, even if it is dried directly, the resulting product is bulky and has high hygroscopicity, so that it is difficult to pulverize and cannot be distributed as a general feed. Furthermore, when yogurt is directly fed, or when mixed with bran and fed as a dried product, the proper use and administration of lactic acid bacteria immunostimulatory substances originally contained in yogurt cannot be achieved, and the effect is sufficient. I didn't get it out.

【0003】一方、食品としてのヨーグルトはその製造
から賞味期限までの保存期間が短く、そのため保存期間
を過ぎたものは廃棄しなければならず、多額の商品ロス
と廃棄するための費用を要するため、製造者にとっては
経営上の大きなマイナスとなっていた。さらにヨーグル
トを生で保存した場合にはヨーグルトに含まれる乳酸菌
類が自己融解あるいは死滅し、乳酸菌類の持つ整腸作用
や免疫賦活物質が失われ、本来食品として持つ機能およ
び価値が低下する等の欠点があった。
[0003] On the other hand, yogurt as a food has a short storage period from its production to the expiration date, so that the product after the storage period must be discarded, resulting in a large amount of product loss and cost for disposal. However, for the manufacturer, it was a great management disadvantage. In addition, when yogurt is stored raw, the lactic acid bacteria contained in the yogurt will self-thaw or die, the intestinal action and immunostimulants possessed by the lactic acid bacteria will be lost, and the function and value originally possessed as food will decrease. There were drawbacks.

【0004】いずれにしても、従来ヨーグルトは単なる
栄養源あるいは蛋白源として用いられるのが現状であ
る。しかも生のままでは保存性が悪いために、飼料ある
いは保存性の高い食品としての流通は困難であり、免疫
賦活作用を持ち長期に安定な製品を製造するための効果
的な手段は未開発であった。
[0004] In any case, yogurt is currently used as a mere nutrient source or protein source. Moreover, since raw foods have poor preservative properties, it is difficult to distribute them as feed or highly preservable foods. Effective means for producing immunostimulatory products that are stable for a long period of time have not yet been developed. there were.

【0005】[0005]

【発明が解決しようとする課題】本発明の目的は、従来
乾燥、粉末化することが困難であった液状または固形ヨ
ーグルトを酵素処理をすることによりカゼイン蛋白を水
に可溶化し効率よく乾燥させ、飼料に配合可能な粉末を
得る方法と、また食品としても長期に保存可能な免疫賦
活物質を含む新しい粉末状ヨーグルトの製造法を提供す
ることにある。
SUMMARY OF THE INVENTION It is an object of the present invention to treat a liquid or solid yogurt, which has conventionally been difficult to dry and pulverize, by enzymatic treatment to solubilize casein protein in water and to dry efficiently. Another object of the present invention is to provide a method for obtaining a powder that can be blended with feed, and a method for producing a new powdered yogurt containing an immunostimulating substance that can be stored for a long time as a food.

【0006】[0006]

【課題を解決するための手段】本発明はヨーグルトを加
熱処理した後、酵素を加えてヨーグルトに含まれる蛋白
質のカゼイン部分を水に可溶化し、必要に応じてデキス
トリンあるいは乳糖を混合して噴霧乾燥法等により乾燥
を行うか、あるいはヨーグルトを加熱処理し次に酵素処
理を行い、続いて界面活性剤を添加後、必要によりデキ
ストリンあるいは乳糖を混合して高圧乳化機による高圧
処理を施し、噴霧乾燥法等により乾燥を行うことによっ
て粉末状のヨーグルトの製造が可能となったのである。
Means for Solving the Problems According to the present invention, after heat treatment of yogurt, an enzyme is added to solubilize the casein portion of the protein contained in yogurt in water, and dextrin or lactose is mixed and sprayed as required. Dry by a drying method, or heat-treat the yogurt, then perform enzyme treatment, then add a surfactant, mix dextrin or lactose as needed, apply high-pressure treatment with a high-pressure emulsifier, and spray Drying by a drying method or the like made it possible to produce powdered yogurt.

【0007】本発明の乾燥物は、ヨーグルトに含まれる
乳酸菌などの含有する免疫賦活物質がヨーグルト粉末中
に失活せず保存されている。本発明により製造されるヨ
ーグルト粉末は、免疫賦活作用を有する飼料用の原料、
あるいは添加物および健康食品などの素材として用いる
ことができる。いずれにしろ、その用途および目的に応
じて本発明の製造法が適用できる。
[0007] In the dried product of the present invention, immunostimulating substances such as lactic acid bacteria contained in yogurt are stored in the yogurt powder without being inactivated. The yogurt powder produced according to the present invention is a feed material having an immunostimulating effect,
Alternatively, it can be used as a material for additives and health foods. In any case, the production method of the present invention can be applied depending on its use and purpose.

【0008】本発明における所望工程としての高圧処理
とは、ヨーグルトを高圧乳化機によって約100〜10
00kg/cm2 の圧力を瞬時にかけることであり、そ
の目的はヨーグルト中に含まれる乳酸菌等の細胞壁から
糖脂質あるいは糖蛋白を効率的に分離し免疫賦活物質の
活性を安定化させるために用いる。
[0008] The high-pressure treatment as a desired step in the present invention means that yogurt is treated with a high-pressure emulsifier for about 100 to 10 minutes.
The purpose is to instantaneously apply a pressure of 00 kg / cm 2 , the purpose of which is to efficiently separate glycolipids or glycoproteins from the cell walls of lactic acid bacteria and the like contained in yogurt to stabilize the activity of the immunostimulatory substance. .

【0009】本発明において使用するデキストリン、乳
糖等は、ヨーグルト乾燥時の製品の付着性および吸着性
を低減する目的で適宜ヨーグルトに対して2%以上添加
する。好ましくはDE値(分解度)が7.0〜12.0
のデキストリンを、ヨーグルトに対して5〜20%使用
することが好ましい。本発明における乾燥法は凍結乾燥
法、噴霧乾燥法、真空乾燥法等の既知の乾燥方法がいず
れも使用されるが、コスト等を考慮し既知の乾燥方法が
選定できる。
The dextrin, lactose and the like used in the present invention are appropriately added to yogurt in an amount of 2% or more for the purpose of reducing the adhesiveness and adsorptivity of the product when the yogurt is dried. Preferably the DE value (resolution) is 7.0 to 12.0
Is preferably used in an amount of 5 to 20% based on yogurt. As the drying method in the present invention, any of known drying methods such as a freeze drying method, a spray drying method, and a vacuum drying method is used, but a known drying method can be selected in consideration of cost and the like.

【0010】[0010]

【作用】このようにして製造された本発明のヨーグルト
粉末は、飼料添加に対し優れた物性を有し、飼料への混
合が容易であるとともに、高い免疫活性を有している。
例えば、マウスに予め本発明のヨーグルト粉末を微量投
与し、その後致死量に相当する大腸菌をマウスに摂取し
た場合に、本ヨーグルト粉末を投与したマウスはそのほ
とんどが生存したが、非投与マウス群では全てあるいは
そのほとんどが死亡した。これらの生物試験によりその
高い免疫賦活作用が立証され、免疫賦活作用を有する飼
料あるいは新しい健康食品の素材としての提供が可能と
なった。
The yogurt powder of the present invention produced in this way has excellent physical properties when added to feed, is easily mixed with feed, and has high immunological activity.
For example, when a small amount of the yogurt powder of the present invention is administered to a mouse in advance and then a lethal dose of Escherichia coli is ingested into the mouse, most of the mice administered with the yogurt powder survive, but in the non-administered mouse group, All or most have died. These biological tests proved its high immunostimulatory effect, and it became possible to provide it as a feed or a new health food material having an immunostimulatory effect.

【0011】本発明に使用するヨーグルトとは、通常、
人の食品および飲用に供されるために製造されたヨーグ
ルトおよびその残滓および賞味期限を過ぎて回収された
もの等で、カード形成により固形化されたものおよび液
状のものでヨーグルトの形態を有するすべてのものを含
む。
The yogurt used in the present invention is usually
Yogurt manufactured for use in human food and drink, and its residues and those collected after the expiration date, all of which are solidified by card formation and liquid and have the form of yogurt Including

【0012】本発明における加熱処理とは、ヨーグルト
の殺菌およびヨーグルト中に含まれる蛋白質の可溶化を
容易にする目的で行われる。好ましくは55〜100
℃、更には80〜95℃に加熱することが好適である。
The heat treatment in the present invention is performed for the purpose of sterilizing yogurt and facilitating the solubilization of proteins contained in yogurt. Preferably 55 to 100
It is preferable to heat to 80C, more preferably 80 to 95C.

【0013】本発明における酵素処理とは、プロテアー
ゼによりヨーグルト中に残存する水に不溶性の蛋白質を
低分子化して、可溶化し効率よく乾燥させ、さらにヨー
グルトに含まれる乳酸菌等の細胞壁から糖蛋白あるいは
糖脂質の分離を容易にするために用いる。用いるプロテ
アーゼは、酸性、中性、およびアルカリプロテアーゼの
いずれでも良いが、酵素の種類によって、あらかじめヨ
ーグルトのpHおよび温度を、用いる酵素の至適範囲に
調整しておく必要がある。プロテアーゼの添加量はヨー
グルト中の蛋白重量に対し、約0.1〜0.5%であ
る。反応時間は通常15分〜60分である。通常本発明
に用いる酵素反応の至適温度は45℃以上55℃以下で
ある。
[0013] The enzyme treatment in the present invention means that the water-insoluble protein remaining in the yogurt is reduced to a low molecular weight by a protease, solubilized and dried efficiently, and the glycoprotein or the lactic acid bacteria contained in the yogurt is removed from the cell wall of lactic acid bacteria or the like. Used to facilitate separation of glycolipids. The protease used may be any of acidic, neutral and alkaline proteases, but it is necessary to adjust the pH and temperature of the yogurt in advance to the optimum range of the enzyme to be used depending on the type of the enzyme. The amount of the protease added is about 0.1 to 0.5% based on the weight of the protein in the yogurt. The reaction time is usually 15 minutes to 60 minutes. Usually, the optimum temperature of the enzyme reaction used in the present invention is 45 ° C. or more and 55 ° C. or less.

【0014】本発明における界面活性剤とはHLB値が
7.0以上の非イオン性界面活性剤を指し、その目的は
ヨーグルト量に対して、0.1〜10%量を添加するこ
とで、ヨーグルト中に含まれる脂肪の分散と乳酸菌等の
細胞壁から糖脂質あるいは糖蛋白の分離を容易にするた
めに用いる。用いる界面活性剤の例としては、ポリオキ
シエチレンソルビタン脂肪酸エステル、ショ糖脂肪酸エ
ステル等があげられ、HLB値が9.0〜15.0のも
のであればよく、ヨーグルト量に対して0.3〜5%添
加することが好適である。
The surfactant in the present invention refers to a nonionic surfactant having an HLB value of 7.0 or more, and its purpose is to add 0.1 to 10% based on the amount of yogurt. It is used for facilitating dispersion of fat contained in yogurt and separation of glycolipid or glycoprotein from cell walls of lactic acid bacteria and the like. Examples of the surfactant used include polyoxyethylene sorbitan fatty acid ester and sucrose fatty acid ester, and the HLB value may be from 9.0 to 15.0. It is preferable to add 〜5%.

【0015】[0015]

【実施例】以下、本発明を実施例を用いてより具体的に
説明する。 〔実施例1〕ヨーグルト2kg(固形分14%)をジャ
ケット付きミキサーに投入し、品温が90℃になるまで
10分間加熱する。加熱後、品温を50℃にまで冷却し
苛性ソーダにてpHを9に調整する。次に、撹拌しなが
らアルカリプロテアーゼ(プロレザー、天野製薬製)を
ヨーグルト量に対し0.15%添加し、50℃で30分
間酵素反応を行う。反応後、品温を95℃にまで上げ酵
素を失活させる。次にヨーグルトの全量に対しショ糖脂
肪酸エステルを0.5%添加する。次にデキストリン2
00gを投入し、充分混合した後、60メッシュの篩で
濾過し濾液を得る。次にこの濾液を高圧乳化機により2
00kg/cm2 の加圧処理し、噴霧乾燥機で入口温度
170℃、出口温度85℃の条件で乾燥させる。その結
果、192gの粉末を得た。
The present invention will be described below more specifically with reference to examples. [Example 1] 2 kg of yogurt (solid content: 14%) is put into a jacketed mixer and heated for 10 minutes until the product temperature becomes 90 ° C. After the heating, the product temperature is cooled to 50 ° C., and the pH is adjusted to 9 with caustic soda. Next, while stirring, an alkali protease (Proleather, manufactured by Amano Pharmaceutical Co., Ltd.) is added in an amount of 0.15% based on the amount of yogurt, and an enzyme reaction is performed at 50 ° C. for 30 minutes. After the reaction, the temperature is raised to 95 ° C. to inactivate the enzyme. Next, 0.5% of sucrose fatty acid ester is added to the whole amount of yogurt. Next, dextrin 2
After adding 00 g and mixing well, the mixture was filtered through a 60-mesh sieve to obtain a filtrate. Next, the filtrate was subjected to a high-pressure emulsifying machine for 2 hours.
It is subjected to a pressure treatment of 00 kg / cm 2 and dried by a spray dryer at an inlet temperature of 170 ° C. and an outlet temperature of 85 ° C. As a result, 192 g of a powder was obtained.

【0016】〔参考例1〕ヨーグルト100kg(固形
分11%)をジャケット付ミキサーに投入し、品温が8
5℃になるまで加熱した。次いで撹拌しながらふすま1
0kgを投入し、ドラムドライヤー100℃の条件で乾
燥した。その結果、16.8kgの塊状物質を得た。
Reference Example 1 100 kg of yogurt (solid content: 11%) was put into a jacketed mixer, and the product temperature was 8
Heated to 5 ° C. Then bran 1 with stirring
Then, 0 kg was charged and dried under the condition of a drum dryer at 100 ° C. As a result, 16.8 kg of a massive substance was obtained.

【0017】上記実施例1および参考例1で得られたヨ
ーグルト粉末を下記の通り投与量を変えてマウスの腹腔
内へ投与し、その後マウスの致死量に相当する大腸菌を
同じマウスの腹腔内へ摂取して、大腸菌接種後のマウス
の生死を観察した。なお対照にはプラセボを投与しその
後同様に大腸菌を接種した。その結果を第1表に示す
が、本発明品は大腸菌の感染に対するマウスの感染抵抗
性を高め、高い免疫賦活活性があることが明らかになっ
た。
The yogurt powders obtained in Example 1 and Reference Example 1 were administered intraperitoneally to mice at different doses as described below, and then E. coli corresponding to the lethal dose of mice was intraperitoneally administered to the same mice. After ingestion, the mice were observed for life and death after inoculation with E. coli. A control was administered with a placebo and then inoculated with Escherichia coli. The results are shown in Table 1, and it was revealed that the product of the present invention increased the infection resistance of mice to infection with Escherichia coli and had high immunostimulatory activity.

【0018】[0018]

【表1】 [Table 1]

【0019】〔試験例〕上記の実施例により得られたヨ
ーグルト粉末を生理食塩水に浮遊させ、マウスの胃内に
ゾンデで浮遊液を直接投与し、投与3日目にマウスの脾
臓を摘出し、10mM−HEPES加MEMで細胞液を
4×106 /mlに調整し、ルミノール反応によるケミ
ルミネッセンスで細胞の貪食能を測定した。その結果、
ヨーグルト粉末を投与したマウスの脾細胞(好中球)
は、貪食能が高まりヨーグルト粉末投与による免疫担当
細胞の活性化が確認された。結果を第2表にグラフ表示
する。
[Test Example] The yogurt powder obtained in the above example was suspended in physiological saline, the suspension was directly administered to the stomach of the mouse by a sonde, and the spleen of the mouse was extracted on the third day after administration. The cell solution was adjusted to 4 × 10 6 / ml with MEM supplemented with 10 mM HEPES, and the phagocytic ability of the cells was measured by chemiluminescence by a luminol reaction. as a result,
Splenocytes (neutrophils) of mice to which yogurt powder was administered
Showed that the phagocytic ability was enhanced and the administration of yogurt powder activated the immunocompetent cells. The results are shown graphically in Table 2.

【0020】 [0020]

───────────────────────────────────────────────────── フロントページの続き (72)発明者 佐 々 木 隆 志 千葉県佐倉市宮前2−15−5 (72)発明者 黒 川 智 裕 群馬県高崎市宮原町8 株式会社科学飼 料研究所社宅B−202 (72)発明者 田 辺 博 埼玉県上福岡市滝2−2−15 (72)発明者 牧 山 真 由 美 群馬県前橋市下新田町16−4 (72)発明者 石 崎 勝 也 千葉県柏市松葉町5−5−11−404 (72)発明者 金 井 弘 幸 埼玉県草加市花栗3−19−14 (56)参考文献 特開 昭49−94867(JP,A) 特開 昭50−5559(JP,A) 特開 平8−89168(JP,A) 特公 昭36−9137(JP,B1) 特公 昭38−23090(JP,B1) 特公 昭51−34465(JP,B2) 欧州特許出願公開303477(EP,A) 欧州特許出願公開303946(EP,A) 欧州特許出願公開63438(EP,A) (58)調査した分野(Int.Cl.6,DB名) A23C 9/12 - 9/137 A23K 1/00 A61K 35/20 ABD EPAT(QUESTEL)──────────────────────────────────────────────────続 き Continued on the front page (72) Inventor Takashi Sasaki 2-15-5 Miyamae, Sakura City, Chiba Prefecture (72) Tomohiro Kurokawa 8 Miyaharacho, Takasaki City, Gunma Prefecture 8 Science Feed Research Institute, Inc. Company house B-202 (72) Inventor Hiroshi Tanabe 2-2-15 Taki, Kamifukuoka-shi, Saitama (72) Inventor Mayumi Makiyama 16-4 Shimoshinada-cho, Maebashi-shi, Gunma (72) Inventor Ishizaki Katsuya 5-5-11-404, Matsuba-cho, Kashiwa City, Chiba Prefecture (72) Inventor Hiroyuki Kanai 3-19-14 Hanaguri, Soka City, Saitama Prefecture (56) References JP-A-49-94867 (JP, A) JP-A-50-5559 (JP, A) JP-A-8-89168 (JP, A) JP-B 36-9137 (JP, B1) JP-B 38-23090 (JP, B1) JP-B 51-34465 (JP, B2) European Patent Application Publication 3034777 (EP, A) European Patent Application Publication 303946 (EP, A) Europe State Patent Application Publication 63438 (EP, A) (58) Fields investigated (Int. Cl. 6 , DB name) A23C 9/12-9/137 A23K 1/00 A61K 35/20 ABD EPAT (QUESTEL)

Claims (6)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 ヨーグルトを55℃〜100℃に加熱し
た後、酵素処理を加えて蛋白質を可溶化した後、乾燥粉
末化することを特徴とする免疫活性を有する酵素処理ヨ
ーグルト粉末の製造法。
1. A method for producing an enzyme-treated yogurt powder having immunological activity, comprising heating yogurt to 55 ° C. to 100 ° C., solubilizing the protein by enzymatic treatment, and then drying the powder.
【請求項2】 使用酵素がプロテアーゼであり、酵素反
応条件が45℃以上である請求項1に記載のヨーグルト
粉末の製造法。
2. The method for producing yogurt powder according to claim 1, wherein the enzyme used is a protease, and the enzyme reaction conditions are 45 ° C. or higher.
【請求項3】 ヨーグルトを55℃〜100℃に加熱
し、酵素を加えて蛋白質を可溶化した後、さらに界面活
性剤を添加した後、乾燥粉末化することを特徴とする免
疫活性を有するヨーグルト粉末の製造法。
3. A yogurt having immunological activity, wherein the yogurt is heated to 55 ° C. to 100 ° C., an enzyme is added to solubilize the protein, a surfactant is further added, and the yogurt is dried and powdered. Powder manufacturing method.
【請求項4】 使用酵素がプロテアーゼであり、酵素反
応条件が45℃以上であり、使用界面活性剤のHLB値
が7以上で、その添加量がヨーグルト量に対し0.1〜
10%である請求項3に記載のヨーグルト粉末の製造
法。
4. The enzyme used is a protease, the enzyme reaction conditions are 45 ° C. or more, the HLB value of the used surfactant is 7 or more, and the amount of the added surfactant is 0.1 to 0.1% with respect to the amount of yogurt.
The method for producing a yogurt powder according to claim 3, which is 10%.
【請求項5】 ヨーグルトを55℃〜100℃に加熱
し、酵素を加えて蛋白質を可溶化した後、さらに高圧乳
化処理を施し、次いで乾燥粉末化することを特徴とする
免疫活性を有するヨーグルト粉末の製造法。
5. A yogurt powder having immunological activity, wherein the yogurt powder is heated to 55 ° C. to 100 ° C., the enzyme is added to solubilize the protein, further subjected to high-pressure emulsification, and then dried into a powder. Manufacturing method.
【請求項6】 高圧乳化処理時の圧力が100〜100
0kg/cm2 である請求項5に記載のヨーグルトの製
造法。
6. The pressure during high-pressure emulsification treatment is 100 to 100.
The method for producing yogurt according to claim 5, wherein the weight is 0 kg / cm 2 .
JP6256250A 1994-09-26 1994-09-26 Method for producing enzyme-treated yogurt powder having immunological activity Expired - Fee Related JP2789553B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6256250A JP2789553B2 (en) 1994-09-26 1994-09-26 Method for producing enzyme-treated yogurt powder having immunological activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6256250A JP2789553B2 (en) 1994-09-26 1994-09-26 Method for producing enzyme-treated yogurt powder having immunological activity

Publications (2)

Publication Number Publication Date
JPH0889166A JPH0889166A (en) 1996-04-09
JP2789553B2 true JP2789553B2 (en) 1998-08-20

Family

ID=17290032

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6256250A Expired - Fee Related JP2789553B2 (en) 1994-09-26 1994-09-26 Method for producing enzyme-treated yogurt powder having immunological activity

Country Status (1)

Country Link
JP (1) JP2789553B2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5134465B2 (en) 2008-07-28 2013-01-30 特許機器株式会社 Vibration isolator

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5134465B2 (en) 2008-07-28 2013-01-30 特許機器株式会社 Vibration isolator

Also Published As

Publication number Publication date
JPH0889166A (en) 1996-04-09

Similar Documents

Publication Publication Date Title
US3260606A (en) Enzymatic treatment of egg
DE69727332T2 (en) Preparations containing collagen, vitamin D3 and calcium to strengthen the bone
JP2001158736A (en) Agent for preventing and improving osteoarthropathy
JPH05292880A (en) Powder with high content of milk-derived complex lipid, production method and use thereof
US2714068A (en) Diacasein and process for its manufacture
JP2001302523A (en) LDL oxidation-suppressed foods and beverages and pharmaceuticals
US3966992A (en) Treatment of soya
JP2862418B2 (en) Functional foods effective for improving lipid metabolism
EP0790060B1 (en) Substance ameliorant le metabolisme des graisses
JP2789553B2 (en) Method for producing enzyme-treated yogurt powder having immunological activity
JP2789554B2 (en) Method for producing alkali-treated yogurt powder having immunological activity
KR100299433B1 (en) Preparation of alcohol-resistant fermentation fermentation and alcohol-resistant fermentation food
EP1302203A1 (en) Stem cell reinforcing material
US2489880A (en) Amino acid compositions and their preparation
KR20220017038A (en) Method for producing bovine bone-derived powder with increased calcium absorption
DE68903171T2 (en) METHOD FOR PRODUCING A COOKING PRODUCT WITH EXTENDED PRESERVATION ON THE BASIS OF ANIMAL PROTEINS.
JP4723501B2 (en) Method for producing peptide mixture, method for producing fermented milk containing antihypertensive peptide and method for producing antihypertensive peptide preparation
Bethke et al. Further Studies on Vitamin G in Chick Nutrition: With Special Reference to Flavins
JPH05320068A (en) Antibacterial agent containing lactoferrin degradation product as an active ingredient, tyrosinase activity inhibitor, and method for treating article using lactoferrin degradation product
JP4084916B2 (en) Antihypertensive food containing raw material derived from wheat
US2576066A (en) Protein purification process and proteinaceous product
Schroeder et al. Influence of heat on the digestibility of meat proteins
JPWO1999062935A1 (en) Reaction product of carboxylic acid and amino acid or amino acid condensate and method for producing the same
JP2998868B2 (en) Intestinal flora improver
JPH08242773A (en) Process for producing calcium-casein phosphopeptide preparation, bone mineral loss suppressing food and bone mineral loss suppressing agent

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 19980428

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090612

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100612

Year of fee payment: 12

LAPS Cancellation because of no payment of annual fees